BioLife Solutions Inc BLFS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $27.09
- Day Range
- $26.15–26.95
- 52-Week Range
- $17.86–29.62
- Bid/Ask
- $24.22 / $29.00
- Shares Outstanding
- 48.86M
- Market Cap
- $1.30B
- Volume/Avg
- 701,948 / 514,543
Key Statistics
- Price/Earnings (Normalized)
- 259.59
- Price/Sales
- 13.05
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 155
- Website
- https://www.biolifesolutions.com
Valuation
|
Metric
|
BLFS
|
|---|---|
Price/Earnings (Normalized) | 259.59 |
Price/Book Value | 3.50 |
Price/Sales | 13.05 |
Price/Cash Flow | 43.52 |
Price/Earnings
BLFS
Financial Strength
|
Metric
|
BLFS
|
|---|---|
Quick Ratio | 5.15 |
Current Ratio | 7.30 |
Interest Coverage | — |
Quick Ratio
BLFS
Profitability
|
Metric
|
BLFS
|
|---|---|
Return on Assets (Normalized) | 1.65% |
Return on Equity (Normalized) | 1.82% |
Return on Invested Capital (Normalized) | 1.09% |
Return on Assets
BLFS
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Gdfbfqtn | Grrc | $149B | |||
| Becton Dickinson & Co
BDX
| Rwfn | Bcqkdlw | $42B | |||
| Alcon Inc
ALC
| Mlqcwdt | Wddwwc | $33B | |||
| ResMed Inc
RMD
| Bzjdzyyqtr | Sftbz | $28B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| Pycshyj | Wdrpwbk | $28B | |||
| West Pharmaceutical Services Inc
WST
| Pmccmyqjtj | Kfzpv | $22B | |||
| Solventum Corp
SOLV
| Dxjjrmtw | Mzbj | $14B | |||
| The Cooper Companies Inc
COO
| Vgncxqpms | Zfyxbn | $13B | |||
| Align Technology Inc
ALGN
| Gtkzwqv | Yxjljqv | $12B | |||
| Baxter International Inc
BAX
| Kqbr | Zwmngw | $10B |
United States